Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume 13, Issue 8, Pages 1103-1113
Publisher
Oxford University Press (OUP)
Online
2010-04-29
DOI
10.1017/s1461145710000453
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain
- (2009) Nancy A. Rigotti et al. ADDICTION
- Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment
- (2009) Ciara McCabe et al. BIOLOGICAL PSYCHIATRY
- Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action
- (2009) Catherine J. Harmer et al. BRITISH JOURNAL OF PSYCHIATRY
- Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control
- (2009) M-H Son et al. INTERNATIONAL JOURNAL OF OBESITY
- Neural representation of reward in recovered depressed patients
- (2009) Ciara McCabe et al. PSYCHOPHARMACOLOGY
- The future of endocannabinoid-oriented clinical research after CB1 antagonists
- (2009) Bernard Le Foll et al. PSYCHOPHARMACOLOGY
- The psychiatric side-effects of rimonabant
- (2009) Fabrício A. Moreira et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats
- (2008) Clare M. Mathes et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats
- (2008) Paola Maccioni et al. BEHAVIOURAL PHARMACOLOGY
- Additive subthreshold dose effects of cannabinoid CB1 receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests
- (2008) Eiki Takahashi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Central Versus Peripheral Antagonism of Cannabinoid CB1 Receptor in Obesity: Effects of LH-21, a Peripherally Acting Neutral Cannabinoid Receptor Antagonist, in Zucker Rats
- (2008) F. J. Pavón et al. JOURNAL OF NEUROENDOCRINOLOGY
- The Effects of Rimonabant on Brown Adipose Tissue in Rat: Implications for Energy Expenditure
- (2008) Aaron N.A. Verty et al. Obesity
- Cognitive influences on the affective representation of touch and the sight of touch in the human brain
- (2008) Ciara McCabe et al. Social Cognitive and Affective Neuroscience
- Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice
- (2007) Michel A. Steiner et al. PSYCHONEUROENDOCRINOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now